靶向抑制TANK结合激酶1表达对舌及下咽鳞癌细胞增殖及凋亡的影响
Effects of Targeted Inhibition of TANK Binding Kinase 1 Expression on Biological Behavior of Squamous Cells Carcinoma of Tongue and Pharynx
王亚平;邱雁君;李玲香;崔晓波;张莉;胡文良;贺利平;
1:内蒙古医科大学附属医院耳鼻咽喉科
2:内蒙古医科大学附属医院重症医学科
摘要关键词基金项目(Foundation):作者参考文献1 Pomerantz JL,Baltimore D.NF-kappaB activation by a signaling complex containing TRAF2,TANK and TBK1,a novel IKK-related kinase[J].EMBO J,1999,18:6694．
2 Bram RJ.TBK1suppression of IgA in the NIK of time[J].Nat Immunol,2012,13:1027．
3 Wei C,Cao Y,Yang X,et al.Elevated expression of TANK-binding kinase 1enhances tamoxifen resistance in breast cancer[J].Proc Natl Acad Sci USA,2014,111:E601．
4 Stinson S,He J,Hollenback D,et al.Anti-tumor activity of a TBK1/IKBKE inhibitor in combination with a MEK inhibitor in KRAS mutant colorectal and non-small cell lung cancer models[J].European Journal of Cancer,2016,69:S146．
5 Chen W,Luo K,Ke Z,et al.TBK1promote bladder cancer cell proliferation and migration via akt signaling[J].J Cancer,2017,8:1892．
6 Cooper JM,Ou YH,McMillan EA,et al.TBK1provides context-selective support of the activated AKT/mTORpathway in lung cancer[J].Cancer Res,2017,77:5077．
7 Wang YP,Lu ZY,Hu ZW,et al.The up-regulation of TANK-binding kinase 1in head and neck squamous cell carcinoma[J].Translational Cancer Research,2017,6:679．
8 Reilly SM,Chiang SH,Decker SJ,et al.An inhibitor of the protein kinases TBK1and IKK-varepsilon improves obesity-related metabolic dysfunctions in mice[J].Nat Med,2013,19:313．
9 Quan MY,Song XJ,Liu HJ,et al.Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses[J].J Neuroinflammation,2019,16:52．
10 Siegel RL,Miller KD,Jemal A.Cancer statistics 2017[J].CA Cancer J Clin,2017,67:7．
11 Saghravanian N,Anvari K,Ghazi N,et al.Expression of p63and CD44in oral squamous cell carcinoma and correlation with clinicopathological parameters[J].Arch Oral Biol,2017,82:160．
12 Zhang D,Fu M,Li L,et al.PKC-delta attenuates the cancer stem cell among squamous cell carcinoma cells through down-regulating p63[J].Pathol Res Pract,2017,213:1119．
13 Wang J,Zhang X,He J,et al.Co-expression of EGFR and CK5/6in primary squamous cell carcinoma of the breast[J].Med Oncol,2014,31:172．
14 Ma Y,Fan M,Dai L,et al.Expression of p63and CK5/6in early-stage lung squamous cell carcinoma is not only an early diagnostic indicator but also correlates with a good prognosis[J].Thorac Cancer,2015,6:288．
15 Gailey MP,Bellizzi AM,Jensen CS.Differentiating small cell carcinoma from squamous cell carcinoma in cytologic specimens:a head-to-head comparison of p40and p63using cell block immunocytochemistry[J].Appl Immunohistochem Mol Morphol,2016,24:11．
16 Kim JY,Beg AA,Haura EB.Non-canonical IKKs,IKKand TBK1,as novel therapeutic targets in the treatment of non-small cell lung cancer[J].Expert Opin Ther Targets,2013,17:1109．
17 Yang KM,Jung Y,Lee JM,et al.Loss of TBK1induces epithelial-mesenchymal transition in the breast cancer cells by ERalpha downregulation[J].Cancer Res,2013,73:6679．
18 Muvaffak A,Pan Q,Yan H,et al.Evaluating TBK1as a therapeutic target in cancers with activated IRF3[J].Mol Cancer Res,2014,12:1055．
19 Liu S,Feng P.MiR-203determines poor outcome and suppresses tumor growth by targeting TBK1in osteosarcoma[J].Cell Physiol Biochem,2015,37:1956．
20 Kim JY,Welsh EA,Oguz U,et al.Dissection of TBK1signaling via phosphoproteomics in lung cancer cells[J].Proc Natl Acad Sci USA,2013,110:12414.